<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335096">
  <stage>Registered</stage>
  <submitdate>2/02/2010</submitdate>
  <approvaldate>14/01/2011</approvaldate>
  <actrnumber>ACTRN12611000051943</actrnumber>
  <trial_identification>
    <studytitle>The chronic effects of thiamin on cardiovascular risk factors in individuals with hyperglycaemia</studytitle>
    <scientifictitle>thiamin supplementation in those with hyperglycaemia: impact on blood lipids, microalbuminaemia and endothelial dysfunction</scientifictitle>
    <utrn>U1111-1113-4931</utrn>
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>hyperglycaemia</healthcondition>
    <healthcondition>dyslipidaemia</healthcondition>
    <healthcondition>microalbuminaemia</healthcondition>
    <healthcondition>reduction of cardiovascular disease risk factors in those with hyperglycaemia</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>100 mg thiamin taken as an oral capsule 3 times per day for 6 weeks in a crossover design which includes a wash-out of approximately 3 mo. After the 3 month wash-out, participants will move onto the placebo treatment and vice versa in the control group.</interventions>
    <comparator>placebo is an identical capsule filled with lactose taken 3 times per day for a total of 6 weeks</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>fasting blood glucose by blood analysis</outcome>
      <timepoint>baseline, 3 and 6 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>blood lipids by blood analysis</outcome>
      <timepoint>baseline and 6 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>urinary albumin by urinanalysis</outcome>
      <timepoint>baseline and 6 weeks</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>fat oxidation during glucose load using gas analysis (medical equipment)</outcome>
      <timepoint>baseline, 3 and 6 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>thiamin status by blood analysis</outcome>
      <timepoint>baseline and 6 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>fasting blood pressure using medical equipment (a vital signs patient monitor)</outcome>
      <timepoint>baseline, 3 and 6 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>hyperglycaemic volunteers with body mass index (BMI) 19-40</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>smoking, known impaired renal or liver function, cardiovascular disease (CVD) event over the last 6 mo, more than 2 std drinks per day, systemic illnesses or use of medications, known allergy or intolerance to thiamin; use of all supplements containing thiamin; pregnancy or lactation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>block randomisation was conducted by a person with no contact with the subjects (allocation concelament). A number was allocated to the intervention and to the control.</concealment>
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>12/05/2009</anticipatedstartdate>
    <actualstartdate>12/05/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>23/05/2010</actualenddate>
    <samplesize>17</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Jill Sherriff</primarysponsorname>
    <primarysponsoraddress>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
Western Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Curtin University</fundingname>
      <fundingaddress>GPO Box U1987
Perth 6845
Western Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Assoc Prof Mario Soares</sponsorname>
      <sponsoraddress>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
Western Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Thiamin or benfotiamine supplementation has been shown to have positive effects on CVD risk factors in animals with experimental diabetes and a few studies of humans with diabetes. This study is designed to see if thiamin has benefts in those with glucose intolerance.</summary>
    <trialwebsite />
    <publication>High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial.
Alaei Shahmiri F, Soares MJ, Zhao Y, Sherriff J.
Eur J Nutr. 2013 Oct;52(7):1821-4. doi: 10.1007/s00394-013-0534-6. Epub 2013 May 29.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Curtin University Human Research Ethics Committee</ethicname>
      <ethicaddress>R&amp;D
GPO Box U1987
Perth 6845
Western Australia</ethicaddress>
      <ethicapprovaldate>8/12/2008</ethicapprovaldate>
      <hrec>161/2008</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Assoc Prof Jill Sherriff</name>
      <address>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
Western Australia</address>
      <phone>+61 8 92667948</phone>
      <fax>+61 8 92662958</fax>
      <email>J.Sherriff@curtin.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Assoc Prof Jill Sherriff</name>
      <address>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
Western Australia</address>
      <phone>+61 8 92667948</phone>
      <fax>+61 8 92662958</fax>
      <email>J.Sherriff@curtin.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Assoc Prof Jill Sherriff</name>
      <address>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
Western Australia</address>
      <phone>+61 8 92667948</phone>
      <fax>+61 8 92662958</fax>
      <email>J.Sherriff@curtin.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jill Sherriff</name>
      <address>School of Public Health
Curtin University
GPO Box U1987
Perth 6845
WA</address>
      <phone>+61 8 9266 7948</phone>
      <fax />
      <email>J.Sherriff@curtin.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>